42 related articles for article (PubMed ID: 34773680)
21. Nanoparticle-Mediated Delivery of STAT3 Inhibitors in the Treatment of Lung Cancer.
Feng Q; Xiao K
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559280
[TBL] [Abstract][Full Text] [Related]
22. Lack of SIRP-alpha reduces lung cancer growth in mice by promoting anti-tumour ability of macrophages and neutrophils.
Pan L; Wang B; Chen M; Ma Y; Cui B; Chen Z; Song Y; Hu L; Jiang Z
Cell Prolif; 2023 Feb; 56(2):e13361. PubMed ID: 36419386
[TBL] [Abstract][Full Text] [Related]
23. Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations.
Tang C; Liu J; Yang C; Ma J; Chen X; Liu D; Zhou Y; Zhou W; Lin Y; Yuan X
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358986
[TBL] [Abstract][Full Text] [Related]
24. Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3
An F; Xuan X; Liu Z; Bian M; Shen Q; Quan Z; Zhang G; Wei C
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956985
[TBL] [Abstract][Full Text] [Related]
25. Targeting Ras-ERK cascade by bioactive natural products for potential treatment of cancer: an updated overview.
Ali ES; Akter S; Ramproshad S; Mondal B; Riaz TA; Islam MT; Khan IN; Docea AO; Calina D; Sharifi-Rad J; Cho WC
Cancer Cell Int; 2022 Aug; 22(1):246. PubMed ID: 35941592
[TBL] [Abstract][Full Text] [Related]
26. New naphthalene derivatives induce human lung cancer A549 cell apoptosis via ROS-mediated MAPKs, Akt, and STAT3 signaling pathways.
Xu WT; Shen GN; Luo YH; Piao XJ; Wang JR; Wang H; Zhang Y; Li JQ; Feng YC; Zhang Y; Zhang T; Wang SN; Wang CY; Jin CH
Chem Biol Interact; 2019 May; 304():148-157. PubMed ID: 30871965
[TBL] [Abstract][Full Text] [Related]
27. Salvia miltiorrhiza polysaccharide activates T Lymphocytes of cancer patients through activation of TLRs mediated -MAPK and -NF-κB signaling pathways.
Chen Y; Li H; Li M; Niu S; Wang J; Shao H; Li T; Wang H
J Ethnopharmacol; 2017 Mar; 200():165-173. PubMed ID: 28232127
[TBL] [Abstract][Full Text] [Related]
28. Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.
Zhang W; Guo J; Li S; Ma T; Xu D; Han C; Liu F; Yu W; Kong L
Sci Rep; 2017 Apr; 7():46352. PubMed ID: 28397855
[TBL] [Abstract][Full Text] [Related]
29. Discovery of New Monocarbonyl Ligustrazine-Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer.
Ai Y; Zhu B; Ren C; Kang F; Li J; Huang Z; Lai Y; Peng S; Ding K; Tian J; Zhang Y
J Med Chem; 2016 Mar; 59(5):1747-60. PubMed ID: 26891099
[TBL] [Abstract][Full Text] [Related]
30. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
[TBL] [Abstract][Full Text] [Related]
31. Anti-Lung Cancer Activities of 1,2,3-Triazole Curcumin Derivatives via Regulation of the MAPK/NF-κB/STAT3 Signaling Pathways.
Zhi TX; Liu KQ; Cai KY; Zhao YC; Li ZW; Wang X; He XH; Sun XY
ChemMedChem; 2022 Feb; 17(3):e202100676. PubMed ID: 34773680
[TBL] [Abstract][Full Text] [Related]
32. Molecular Pathways Modulated by Curcumin Analogue, Diarylpentanoids in Cancer.
Paulraj F; Abas F; H Lajis N; Othman I; Naidu R
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31295798
[TBL] [Abstract][Full Text] [Related]
33. Impact of curcumin on p38 MAPK: therapeutic implications.
Shamsnia HS; Roustaei M; Ahmadvand D; Butler AE; Amirlou D; Soltani S; Momtaz S; Jamialahmadi T; Abdolghaffari AH; Sahebkar A
Inflammopharmacology; 2023 Oct; 31(5):2201-2212. PubMed ID: 37498375
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
